| Substance | Condition | Seq | Src | PMID | Dtl | Title |
| Ginsenosides | Cervical Cancer | 17 | PM | 37720575 | 📋 | Ginsenoside Rk1 inhibits HeLa cell proliferation through an endoplasmic reticulum signaling pathway |
| Ginsenosides | Cervical Cancer | 16 | PM | 37664735 | 📋 | Ginsenoside Rg3 inhibits the malignant progression of cervical cancer cell by regulating AKT2 expression |
| Ginsenosides | Cervical Cancer | 14 | PM | 36431966 | 📋 | Ginsenoside Rh2 Induces HeLa Apoptosis through Upregulating Endoplasmic Reticulum Stress-Related and Downstream Apoptotic Gene Expression |
| Ginsenosides | Cervical Cancer | 13 | PM | 35885925 | 📋 | Ginsenoside Rg5 Sensitizes Paclitaxel-Resistant Human Cervical-Adeno-Carcinoma Cells to Paclitaxel-And Enhances the Anticancer Effect of Paclitaxel |
| Ginsenosides | Cervical Cancer | 12 | PM | 34718401 | 📋 | 20(S)-ginsenoside Rh2-induced apoptosis and protective autophagy in cervical cancer cells by inhibiting AMPK/mTOR pathway |
| Ginsenosides | Cervical Cancer | 11 | PM | 34713297 | 📋 | Ginsenoside Rh2 stimulates the production of mitochondrial reactive oxygen species and induces apoptosis of cervical cancer cells by inhibiting mitochondrial electron transfer chain complex |
| Ginsenosides | Cervical Cancer | 10 | PM | 34013944 | 📋 | Ginsenoside CK induces apoptosis of human cervical cancer HeLa cells by regulating autophagy and endoplasmic reticulum stress |
| Ginsenosides | Cervical Cancer | 9 | PM | 33986832 | 📋 | Total ginsenosides induce autophagic cell death in cervical cancer cells accompanied by downregulation of bone marrow stromal antigen-2 |
| Ginsenosides | Cervical Cancer | 8 | PM | 33784737 | 📋 | Knockdown of p62/sequestosome enhances ginsenoside Rh2-induced apoptosis in cervical cancer HeLa cells with no effect on autophagy |
| Ginsenosides | Cervical Cancer | 7 | PM | 33537816 | 📋 | Notoginsenoside R1 induces DNA damage via PHF6 protein to inhibit cervical carcinoma cell proliferation |
| Ginsenosides | Cervical Cancer | 6 | PM | 33292331 | 📋 | Ginsenoside Rh2 represses autophagy to promote cervical cancer cell apoptosis during starvation |
| Ginsenosides | Cervical Cancer | 5 | PM | 33000213 | 📋 | Ginsenoside Rh2 inhibits HeLa cell energy metabolism and induces apoptosis by upregulating voltage‑dependent anion channel 1 |
| Ginsenosides | Cervical Cancer | 1 | PM | 31658733 | 📋 | 20(S)-Ginsenoside Rg3 Promotes HeLa Cell Apoptosis by Regulating Autophagy |
| Ginsenosides | Cervical Cancer | 3 | PM | 29363731 | 📋 | Ginsenoside 20(S)-Rh2 Exerts Anti-Cancer Activity Through the Akt/GSK3β Signaling Pathway in Human Cervical Cancer Cells |
| Ginsenosides | Cervical Cancer | 15 | PM | 29312623 | 📋 | Notoginsenoside R7 suppresses cervical cancer via PI3K/PTEN/Akt/mTOR signaling |
| Ginsenosides | Cervical Cancer | 4 | PM | 25355274 | 📋 | Ginsenoside‑Rg5 induces apoptosis and DNA damage in human cervical cancer cells |
| Ginsenosides | Cervical Cancer | 2 | PM | 25226895 | 📋 | 20(s)-ginsenoside Rg3-loaded Magnetic Human Serum Albumin Nanospheres Applied to HeLa Cervical Cancer Cells in Vitro |
| Ginsenosides | Endometrial Cancer | 4 | PM | 37625321 | 📋 | Ginsenosides in endometrium-related diseases: Emerging roles and mechanisms |
| Ginsenosides | Endometrial Cancer | 3 | PM | 33437164 | 📋 | Ginsenoside 20(S)-protopanaxadiol induces cell death in human endometrial cancer cells via apoptosis |
| Ginsenosides | Endometrial Cancer | 1 | PM | 29078265 | 📋 | Ginsenoside Rh2 induces apoptosis and inhibits epithelial-mesenchymal transition in HEC1A and Ishikawa endometrial cancer cells |
| Ginsenosides | Endometrial Cancer | 2 | PM | 11766734 | 📋 | Inhibitory effect of ginsenoside-Rb2 on invasiveness of uterine endometrial cancer cells to the basement membrane |
| Ginsenosides | Ovarian Cancer | 18 | PM | 38223825 | 📋 | Ginsenoside 20(S)-Rg3 reduces KIF20A expression and promotes CDC25A proteasomal degradation in epithelial ovarian cancer |
| Ginsenosides | Ovarian Cancer | 16 | PM | 34038042 | 📋 | Ginsenoside Rg3 suppresses ovarian cancer cell proliferation and invasion by inhibiting the expression of lncRNA H19 |
| Ginsenosides | Ovarian Cancer | 15 | PM | 33509760 | 📋 | [Ginsenoside 20(S)-Rg3 upregulates tumor suppressor VHL gene expression by suppressing DNMT3A-mediated promoter methylation in ovarian cancer cells] |
| Ginsenosides | Ovarian Cancer | 14 | PM | 32877662 | 📋 | 20(S)-Rg3 upregulates FDFT1 via reducing miR-4425 to inhibit ovarian cancer progression |
| Ginsenosides | Ovarian Cancer | 1 | PM | 32151067 | 📋 | Ginsenoside Rp1, A Ginsenoside Derivative, Augments Anti-Cancer Effects of Actinomycin D via Downregulation of an AKT-SIRT1 Pathway |
| Ginsenosides | Ovarian Cancer | 12 | PM | 31002353 | 📋 | Effects of ginsenoside Rg3 on epigenetic modification in ovarian cancer cells |
| Ginsenosides | Ovarian Cancer | 2 | PM | 30481782 | 📋 | Ginsenoside 20(S)-Rg3 Prevents PKM2-Targeting miR-324-5p From H19 Sponging to Antagonize the Warburg Effect in Ovarian Cancer Cells |
| Ginsenosides | Ovarian Cancer | 13 | PM | 29558748 | 📋 | Ginsenoside 20(S)-Rg3 Inhibits the Warburg Effect Via Modulating DNMT3A/ MiR-532-3p/HK2 Pathway in Ovarian Cancer Cells |
| Ginsenosides | Ovarian Cancer | 11 | PM | 28928801 | 📋 | Ginsenoside Rb1 inhibits hypoxia-induced epithelial-mesenchymal transition in ovarian cancer cells by regulating microRNA-25 |
| Ginsenosides | Ovarian Cancer | 7 | PM | 28459376 | 📋 | Ginsenoside 20(S)-Rg3 Suppresses Ovarian Cancer Migration via Hypoxia-Inducible Factor 1 Alpha and Nuclear Factor-Kappa B Signals |
| Ginsenosides | Ovarian Cancer | 10 | PM | 27959575 | 📋 | Effect of ginsenoside Rh-2 via activation of caspase-3 and Bcl-2-insensitive pathway in ovarian cancer cells |
| Ginsenosides | Ovarian Cancer | 6 | PM | 27899249 | 📋 | Ginsenoside 20(S)-Rg3 Induced Autophagy to Inhibit Migration and Invasion of Ovarian Cancer |
| Ginsenosides | Ovarian Cancer | 17 | PM | 27825116 | 📋 | Ginsenoside-Rb1 targets chemotherapy-resistant ovarian cancer stem cells via simultaneous inhibition of Wnt/β-catenin signaling and epithelial-to-mesenchymal transition |
| Ginsenosides | Ovarian Cancer | 9 | PM | 25405516 | 📋 | Ginsenoside 20(S)‑Rg3 Inhibits the Warburg Effect Through STAT3 Pathways in Ovarian Cancer Cells |
| Ginsenosides | Ovarian Cancer | 8 | PM | 25197976 | 📋 | Ginsenoside 20(S)-Rg3 Targets HIF-1α to Block Hypoxia-Induced Epithelial-Mesenchymal Transition in Ovarian Cancer Cells |
| Ginsenosides | Ovarian Cancer | 5 | PM | 25168366 | 📋 | 20(s)-ginsenoside Rg3 Promotes Apoptosis in Human Ovarian Cancer HO-8910 Cells Through PI3K/Akt and XIAP Pathways |
| Ginsenosides | Ovarian Cancer | 3 | PM | 17442207 | 📋 | Inhibitory Effect of Ginsenoside Rg3 Combined With Cyclophosphamide on Growth and Angiogenesis of Ovarian Cancer |
| Ginsenosides | Ovarian Cancer | 4 | PM | 1958854 | 📋 | Inhibition of Human Ovarian Cancer Cell Proliferation in Vitro by Ginsenoside Rh2 and Adjuvant Effects to Cisplatin in Vivo |
